These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23728364)

  • 1. Anesthetic management of the patient with amyotrophic lateral sclerosis.
    Prabhakar A; Owen CP; Kaye AD
    J Anesth; 2013 Dec; 27(6):909-18. PubMed ID: 23728364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amyotrophic lateral sclerosis--diagnosis and treatment].
    Jung HH; Neumann M; Bloch KE
    Praxis (Bern 1994); 2012 Jul; 101(14):907-14. PubMed ID: 22763933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyotrophic Lateral Sclerosis and the Respiratory System.
    Braun AT; Caballero-Eraso C; Lechtzin N
    Clin Chest Med; 2018 Jun; 39(2):391-400. PubMed ID: 29779597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amyotrophic lateral sclerosis.
    Gordon PH; Mitsumoto H; Hays AP
    Sci Aging Knowledge Environ; 2003 Sep; 2003(35):dn2. PubMed ID: 12954882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole and ALS therapy.
    Hugon J
    Wien Med Wochenschr; 1996; 146(9-10):185-7. PubMed ID: 8873431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
    Yanagisawa N; Shindo M
    Rinsho Shinkeigaku; 1996 Dec; 36(12):1329-30. PubMed ID: 9128396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.
    Bruneteau G; Simonet T; Bauché S; Mandjee N; Malfatti E; Girard E; Tanguy ML; Behin A; Khiami F; Sariali E; Hell-Remy C; Salachas F; Pradat PF; Fournier E; Lacomblez L; Koenig J; Romero NB; Fontaine B; Meininger V; Schaeffer L; Hantaï D
    Brain; 2013 Aug; 136(Pt 8):2359-68. PubMed ID: 23824486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From Riluzole to Dexpramipexole via Substituted-Benzothiazole Derivatives for Amyotrophic Lateral Sclerosis Disease Treatment: Case Studies.
    Mignani S; Majoral JP; Desaphy JF; Lentini G
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32707914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapies in development that inhibit motor neuron hyperexcitability in amyotrophic lateral sclerosis.
    Noto Y; Shibuya K; Vucic S; Kiernan MC
    Expert Rev Neurother; 2016 Oct; 16(10):1147-54. PubMed ID: 27314534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provincial Differences in the Diagnosis and Care of Amyotrophic Lateral Sclerosis.
    Hodgkinson VL; Lounsberry J; Mirian A; Genge A; Benstead T; Briemberg H; Grant I; Hader W; Johnston WS; Kalra S; Linassi G; Massie R; Melanson M; O'Connell C; Schellenberg K; Shoesmith C; Taylor S; Worley S; Zinman L; Korngut L
    Can J Neurol Sci; 2018 Nov; 45(6):652-659. PubMed ID: 30430962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intact single muscle fibres from SOD1
    Cheng AJ; Allodi I; Chaillou T; Schlittler M; Ivarsson N; Lanner JT; Thams S; Hedlund E; Andersson DC
    J Physiol; 2019 Jun; 597(12):3133-3146. PubMed ID: 31074054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-modifying therapies in amyotrophic lateral sclerosis.
    Chiò A; Mazzini L; Mora G
    Neuropharmacology; 2020 May; 167():107986. PubMed ID: 32062193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocatechuic Acid Extends Survival, Improves Motor Function, Diminishes Gliosis, and Sustains Neuromuscular Junctions in the hSOD1
    Koza LA; Winter AN; Holsopple J; Baybayon-Grandgeorge AN; Pena C; Olson JR; Mazzarino RC; Patterson D; Linseman DA
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32570926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade?
    Bellingham MC
    CNS Neurosci Ther; 2011 Feb; 17(1):4-31. PubMed ID: 20236142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of the Cardiovascular Drug Levosimendan in the Management of Amyotrophic Lateral Sclerosis: An Overview of a Working Hypothesis.
    Al-Chalabi A; Heunks LMA; Papp Z; Pollesello P
    J Cardiovasc Pharmacol; 2019 Nov; 74(5):389-399. PubMed ID: 31730560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasciculation discharge frequency in amyotrophic lateral sclerosis and related disorders.
    de Carvalho M; Swash M
    Clin Neurophysiol; 2016 May; 127(5):2257-62. PubMed ID: 27072098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study.
    Deeb O; Nabulsi M
    Curr Top Med Chem; 2020; 20(26):2391-2403. PubMed ID: 32972341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis.
    Marvulli R; Megna M; Citraro A; Vacca E; Napolitano M; Gallo G; Fiore P; Ianieri G
    Toxins (Basel); 2019 Jul; 11(7):. PubMed ID: 31266172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural compounds used as therapies targeting to amyotrophic lateral sclerosis.
    Nabavi SF; Daglia M; D'Antona G; Sobarzo-Sánchez E; Talas ZS; Nabavi SM
    Curr Pharm Biotechnol; 2015; 16(3):211-8. PubMed ID: 25601606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.